In patients with refractory B-cell lymphoma receiving CD19-CAR-Ts, tumor-associated macrophage infiltration was inversely correlated with remission, implicating that the presence of macrophages in the TME impairs CAR-Ts’ function [155] (Figure 2). Here, CD19 is linked to neoplasm.